Perspective on Quantitative Structure–Toxicity Relationship (QSTR) Models to Predict Hepatic Biotransformation of Xenobiotics

• Published in: Livers 2023-09, Vol.3 (3), p.448-462
• Main Authors: Rai, Mansi, Paudel, Namuna, Sakhrie, Mesevilhou, Gemmati, Donato, Khan, Inshad Ali, Tisato, Veronica, Kanase, Anurag, Schulz, Armin, Singh, Ajay Vikram
• Format: Article
• Language: English
• Subjects: Chemicals; computational prediction; Cytochrome; Enzymes; hepatic biotransformation; Herbicides; Hydrogen; Liver; Metabolism; Metabolites; Molecular weight; Pesticides; Pharmacokinetics; Toxicity; xenobiotics
• ISSN: 2673-4389; 2673-4389
• DOI: 10.3390/livers3030032

Biotransformation refers to the metabolic conversion of endogenous and xenobiotic chemicals into more hydrophilic substances. Xenobiotic biotransformation is accomplished by a restricted number of enzymes with broad substrate specificities. The biotransformation of xenobiotics is catalyzed by various enzyme systems that can be divided into four categories based on the reaction they catalyze. The primary concentration is in cytochrome P450, while the CYP enzymes responsible for xenobiotic biotransformation are located within the hepatic endoplasmic reticulum (microsomes). Cytochrome P450 (CYP450) enzymes are also present in extrahepatic tissues. Enzymes catalyzing biotransformation reactions often determine the intensity and duration of the action of drugs and play a key role in chemical toxicity and chemical tumorigenesis. The structure of a given biotransforming enzyme may differ among individuals, which can cause differences in the rates of xenobiotic biotransformation. The study of the molecular mechanisms underlying chemical liver injury is fundamental for preventing or devising new modalities of treatment for liver injury using chemicals. Active metabolites arise from the biotransformation of a parent drug compound using one or more xenobiotic-processing enzymes to generate metabolites with different pharmacological or toxicological properties. Understanding how exogenous chemicals (xenobiotics) are metabolized, distributed, and eliminated is critical to determining the impact of these compounds on human health. Computational tools such as Biotransformer have been developed to predict all the possible metabolites of xenobiotic and enzymatic profiles that are linked to the production of metabolites. The construction of xenobiotic metabolism maps can predict enzymes catalyzing metabolites capable of binding to DNA.